Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-07-02

Clinical Trial Update: Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids) [Phase 2]

View source ↗

Summary

Phase 2 trial of a non-invasive treatment for uterine leiomyoma (fibroids) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | Conditions: Uterine Leiomyoma, Fibroids | Phase 2 | Status: COMPLETED